Nuvo Research Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Greg Spendjian who wrote (8577)	1/29/2002 3:02:09 PM
From: shakedown	Read Replies (1) of 14101

Greg, Maybe this is the reason why there is no information on HIV + patient's survival rate when using WF10 in Thailand. Here is what WF10 is approved for in Thailand: The company's lead drug, WF10, is approved for use in Thailand under the name IMMUNOKINE(TM), in patients with postradiation chronic inflammatory diseases including cystitis, proctitis and mucositis. askemilyss.com also: In Thailand, the product [WF10] is already approved for treatment of inflammatory disorders caused by irradiation biospace.com i.e. it is not approved for use against AIDS in Thailand, at least I can't find any indication that it is (let me know if you find a link). This is not to say that people aren't being prescribed it anyway (I really have no idea! Mark any thoughts?). But this may preclude Oxo from discussing survival rates. Can you see me way out on this limb? Warren

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next